Detalhe da pesquisa
1.
Efficacy and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir for Hepatitis C Virus (HCV) NS5A-Inhibitor Experienced Patients With Difficult to Cure Characteristics.
Clin Infect Dis;
73(9): e3288-e3295, 2021 11 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32887983
2.
Assessment of a primary care e-support package of automated case finding, simplified treatment algorithm and decision support to increase hepatitis B treatment uptake in primary care clinics in Australia (SIMPLY-B Study): protocol for a pilot evaluation.
BMJ Open;
13(3): e070663, 2023 03 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36927591